The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...
In mCRPC patients with androgen receptor (AR) mutations, treatment with MRT-2359 in combination with enzalutamide led to a 100% PSA response rate (4 of 4 patients) and a 100% disease control rate, ...
The marathon surgical session, conducted between 8 am and 5 pm, was led by Dr (prof) Santosh Kumar, with the procedures ...
ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...
A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment ...
CHAD Thompson grappled with a silent problem for 20 years – he couldn’t pee properly, and it was a constant source of anxiety ...
Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...
Darts fans have just a few more hours to enter to win the opportunity to throw nine darts on stage at Alexandra Palace - with ...
For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently ...
Brian Milne was 64 when he was diagnosed with incurable prostate cancer, but a new treatment means he is still thriving 10 years later ...
Using cancer’s own survival tricks against it, scientists may have found a new way to stay one step ahead of the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback